Published on: 17-Mar-17

AI for New Therapies in Rare Diseases

Our partners leverage EvolverAI to augment R&D decisions and increase
probability of success (POS) by performing complex therapeutic area focused queries with with hundreds-to-thousands of proprietary therapeutic area specific probes designed by our drug discovery and translational experts resulting in disease association maps that are further analyzed using proprietary, predictive algorithms to generate new hypotheses(right drug–right disease–right patient)

Published on: 18-Jan-17

AI for Selection of Combination Therapies

EvolverAI is designed to optimize therapeutic value of drugs, therapeutic modalities, disease biology and diseases.
Our partners leverage EvolverAI to augment R&D decisions and increase probability of success (POS) by performing complex therapeutic area focused queries.